TYKERB(R) (Lapatinib) To Be Investigated In Landmark Early Breast Cancer Trial
May 15th 2008Drug InformationBreast Cancer
GlaxoSmithKline (GSK), in collaboration with the Breast International Group (BIG), a leading academic breast cancer research network, and one of its member groups, the Spanish Breast Cancer Cooperative Group (SOLTI), announced the start of a global Phase III study that will examine the role of TYKERB(R) in the treatment of early breast cancer.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
